to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Kurt Yilmaz, Nese
One or more keywords matched the following items that are connected to
Kurt Yilmaz, Nese
Structural and Thermodynamic Effects of Macrocyclization in HCV NS3/4A Inhibitor MK-5172.
Molecular Basis for Differential Patterns of Drug Resistance in Influenza N1 and N2 Neuraminidase.
Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
Hepatitis C Virus NS3/4A Protease Inhibitors Incorporating Flexible P2 Quinoxalines Target Drug Resistant Viral Variants.
Molecular Mechanism of Resistance in a Clinically Significant Double-Mutant Variant of HCV NS3/4A Protease.
Mavyret: A Pan-Genotypic Combination Therapy for the Treatment of Hepatitis C InfectionPublished as part of the Biochemistry series "Biochemistry to Bedside".
Molecular and Structural Mechanism of Pan-Genotypic HCV NS3/4A Protease Inhibition by Glecaprevir.
Avoiding Drug Resistance by Substrate Envelope-Guided Design: Toward Potent and Robust HCV NS3/4A Protease Inhibitors.
Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond.
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188.
Inhibiting HTLV-1 Protease: A Viable Antiviral Target.
Discovery of Quinoxaline-Based P1-P3 Macrocyclic NS3/4A Protease Inhibitors with Potent Activity against Drug-Resistant Hepatitis C Virus Variants.
Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode.
Viral proteases: Structure, mechanism and inhibition.
Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance.
Allosteric quinoxaline-based inhibitors of the flavivirus NS2B/NS3 protease.
Crystal Structures of Inhibitor-Bound Main Protease from Delta- and Gamma-Coronaviruses.